A meta-analysis of randomized controlled trials of intermittent IFA supplementation among adolescents and women of reproductive age found a mean 35% reduction in the risk of anemia and a 0.52 g/dL increase in Hb (31). The gene discussed is GSTM1; the disease is anemia.